News & Updates
Filter by Specialty:
Higher serum 25(OH)D concentration tied to lower CVD, deaths in CKD
Increased concentrations of serum 25-hydroxyvitamin D (25[OH]D) appear to have beneficial effects in patients with chronic kidney disease (CKD), as indicated by lower risks of cardiovascular disease (CVD) incidence and mortality, as shown in a prospective study.
Higher serum 25(OH)D concentration tied to lower CVD, deaths in CKD
10 Jun 2024
Reduced-dose DOACs tied to lower stroke incidence vs warfarin
Patients with atrial fibrillation receiving a reduced dose of direct acting oral anticoagulants (DOAC), particularly rivaroxaban and dabigatran, show a similar incidence of ischaemic stroke and systemic embolism to those receiving warfarin, a study has shown.
Reduced-dose DOACs tied to lower stroke incidence vs warfarin
10 Jun 2024
Testosterone therapy in women may lower risks of MACE, breast cancer
Women on testosterone therapy (TTh) show a lower risk of major adverse cardiac events (MACE) than matched controls, while postmenopausal women have a comparable MACE risk and a similar or significantly reduced risk of breast cancer on age-based subanalysis, reports a study.
Testosterone therapy in women may lower risks of MACE, breast cancer
04 Jun 2024
Increasing trend in DOAC-related intracerebral haemorrhage: How to improve outcomes?
New local findings presented at HKMF 2024 show an increasing trend in intracerebral haemorrhage (ICH) among patients on direct oral anticoagulants (DOACs) between 2013 and 2022. Early initiation of reversal agents may improve outcomes in select cases with DOAC-related ICH.